Insider Activity at MACOM Technology Solutions – What the Latest Buy by Dennehy Robert Means
On October 21, 2026, Senior Vice President and Chief Operating Officer Robert Dennehy added 2,104 shares to his MACOM position, receiving a modest $0.00 per‑share price because the transaction was a grant of restricted stock units (RSUs). The RSUs are set to vest in 2027, 2028 and 2029, and they will count toward Dennehy’s ownership of 14,862 shares after the purchase. The move comes at a time when MACOM’s share price has fallen 9.9% in the last week and 14.4% over the month, while the company’s long‑term trend remains bullish, with a 61.4% year‑to‑date gain.
The new RSU grant signals confidence from management that MACOM’s strategic initiatives—particularly its focus on high‑frequency analog solutions for 5G and satellite communications—are on track. RSU awards are typically granted only when executives expect the stock to rise, and they align insider incentives with shareholders. In an industry where rapid technological shifts can erode margins, this grant may be interpreted as a vote of confidence in MACOM’s product roadmap and the leadership team’s ability to execute.
What Investors Should Take Away
Positive Insider Signal: While the grant itself is non‑cash and does not move the market immediately, it is a clear indicator that insiders believe the stock will rebound. Coupled with the recent social‑media buzz—over 677 % activity and a sentiment score of +4—there is a growing narrative that MACOM could be undervalued relative to its 52‑week high of $418.90.
Potential for Share Price Recovery: The company’s earnings multiples (P/E 87.4) suggest that valuation is high compared to peers, yet the long‑term growth prospects, especially in the millimeter‑wave space, justify a higher multiple. If the broader market recovers and MACOM’s guidance remains strong, a rebound could be within reach.
Risk of Volatility: The sector remains sensitive to macroeconomic conditions. Any slowdown in semiconductor demand or supply‑chain disruptions could dampen the upside. Investors should monitor MACOM’s quarterly guidance and any changes in executive compensation tied to performance metrics.
Dennehy Robert – A Profile Based on Insider Moves
Dennehy’s insider history shows a pattern of both buying and selling, but the recent activity indicates a strategic approach:
| Date | Action | Shares | Post‑Trade Holdings |
|---|---|---|---|
| 2026‑08‑28 | Sell | 252 | 12,758 |
| 2026‑05‑15 | Buy | 146 | 13,010 |
| 2026‑02‑26 | Sell | 971 | 30,291 |
| 2025‑11‑25 | Buy | 1,232 | 31,262 |
| 2024‑02‑?? | — | — | — |
Key observations:
- Periodic Large Sales: The February 2026 sales (total ~15,000 shares) were executed at prices above the market, suggesting a tactical divestment, perhaps to fund personal liquidity or diversify holdings.
- RSU Grants and Purchases: The August 2025 buy of 1,232 shares and the October 2026 RSU grant both occurred when the share price was below the 52‑week low, indicating Dennehy’s willingness to commit when the market is depressed.
- Balanced Portfolio Management: Dennehy’s holdings have fluctuated but remain in the 13,000‑15,000 share range, showing a steady, long‑term stake rather than speculative swings.
Overall, Dennehy’s transaction history paints a picture of an insider who actively manages liquidity while maintaining a substantial, long‑term interest in the company’s success.
Conclusion
The October 21 RSU grant by Robert Dennehy, set against a backdrop of heightened social‑media buzz and a declining share price, offers a cautiously optimistic outlook for MACOM Technology Solutions. Investors should view this as a green light from senior management and consider MACOM’s growth prospects in the high‑frequency semiconductor market. As always, a careful assessment of the broader market environment and the company’s upcoming earnings will be essential to gauge whether the potential upside materializes.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-10-21 | Dennehy Robert (Senior VP and COO) | Buy | 2,104.00 | N/A | Common Stock |
| 2026-10-21 | Hwang Donghyun Thomas (SVP, Global Sales) | Buy | 1,439.00 | N/A | Common Stock |
| 2026-10-21 | Roth Ambra R. (SVP, GC and Secretary) | Buy | 1,401.00 | N/A | Common Stock |
| 2026-10-21 | Kober John (Senior VP and CFO) | Buy | 2,277.00 | N/A | Common Stock |




